Sai Life Sciences IPO listing: Sai Life Sciences shares made a strong debut on Wednesday, December 18 as they listed at ₹650 on NSE, a premium of 18.4 percent over the issue price of ₹549.

Be sure to monitor the stock for price movements and market conditions. Eris Lifesciences: Promising Swing Trade Opportunity Eris Lifesciences, a leading pharmaceutical company specializing in branded ...

The IPO of Sai Life Sciences, which is backed by the global private equity major TPG Capital, was off to a decent start on December 11, the first day of subscription, as the issue was subscribed ...

Ireland’s internationally renowned life sciences sector wasn’t built in a day; and over the past six decades the industry has contributed to the Republic’s economic success in a way that is ...

Explore the breadth of our life sciences degrees, spanning the full breadth of life sciences from molecules through to ecosystems. Learn more about the expertise of our research labs where we deliver ...

Sai Life Sciences provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule New Chemical Entities (NCE), to global pharmaceutical innovator ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...